drugset / Trial / NCT00219388

Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.

NCT00219388

Phase 4 Completed 60 enrolled Orion Corporation, Orion Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effects of levosimendan with dobutamine on heart function in patients suffering of severe chronic heart failure.

Timeline

Start
2002-11
Primary completion
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Levosimendan Other / unclassified Intravenous

Indications